Lyka Labs Ltd | Small-cap | Healthcare
₹110.57
0.48%
| Lyka Labs Stock Comparison:
No comparison data available
Chart Range Statistics Financials Returns Ownership Calculator FAQ

Lyka Labs Performance Comparison

Loading chart data...

Lyka Labs
NIFTY 50
View Full Price History

Stock Range

Today's Range

Low: ₹107.80 High: ₹112.00
on July 9, 2025

52 Week Range

Low: ₹96.80 High: ₹176.59
on April 7, 2025
on December 10, 2024

All-Time High: ₹267.00 on December 20, 2021

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR4.0B
EPS i N/A
P/E Ratio (TTM) i 50.00
Forward P/E i N/A
P/B Ratio i 3.88
PEG Ratio i N/A
Div. Yield i N/A
ROE i 9.23%
Beta i N/A
Debt to Equity i 37.83

Financial Highlights

Profitability

Gross Margin i 60.86%
Operating Margin i N/A
Profit Margin i N/A

Returns and Earnings

Return on Assets (TTM) i N/A
Return on Equity (TTM) i 9.23%
EBITDA i N/A
Net Income (TTM) i N/A

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i
Quarterly Revenue Growth i
Quarterly Earnings Growth i

Peer Performance Comparison

No peer performance data available for this stock.

Ownership & Short Interest

Insider Ownership i 61.12%
Institutional Ownership i 0.00%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 65K
Average 90-Day Volume i 75K

Lyka Labs Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Lyka Labs would have performed over time.

INR
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is LYKALABS's 52-week high and low?

In the last 52 weeks, Lyka Labs reached a high of ₹176.59 (on December 10, 2024) and a low of ₹96.80 (on April 7, 2025).

What is the market cap and P/E ratio for LYKALABS?

Curious about Lyka Labs's size and valuation? Its market capitalization stands at 3.96B. When it comes to valuation, the P/E ratio (trailing twelve months) is 50.00, and the forward P/E (looking ahead) is N/A.

Does LYKALABS pay dividends? If so, what's the yield?

As for dividends, Lyka Labs isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Lyka Labs's main competitors or similar companies to consider before investing?

When looking at Lyka Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

No specific competitor data is currently available for comparison in this section.

What are the key financial health indicators for Lyka Labs Ltd? (e.g., ROE, Debt/Equity)

To get a sense of Lyka Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.23%, the Debt to Equity ratio from the most recent quarter is 37.83, and its Gross Profit Margin stands at 60.86%.

What is the recent revenue and earnings growth for LYKALABS?

Looking at Lyka Labs's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 46.90%, and quarterly earnings saw a YoY growth of 54.01%.

How much of LYKALABS stock is held by insiders and institutions?

Wondering who owns Lyka Labs stock? Company insiders (like executives and directors) hold about 61.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.